recormon 4000 i.u. 6 pref. syringes
ريكورمون 4000وحدة دولية 6 سرنجات معبأة للحقن
erythropoietin-betaThe published official price. Pharmacies may differ slightly.
- Strength
- 4000 i.u
- Form
- syringe
- Manufacturer
- f.hoffman la roche > hoffmann la-roche ltd
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Erythropoietin-beta is indicated for the treatment of anemia associated with chronic kidney disease in patients on dialysis and pre-dialysis, and for anemia in patients with non-myeloid malignancies receiving chemotherapy.
Do not use if
Contraindicated in patients with uncontrolled hypertension and in those with known hypersensitivity to erythropoietin-beta or any component of the formulation. Not recommended for use as a substitute for red blood cell transfusions in patients requiring immediate correction of anemia.
Side effects
Common side effects include hypertension, flu-like symptoms, headache, and injection site reactions. Serious risks include thrombotic events, pure red cell aplasia (a rare but severe complication), and worsening hypertension.
Warnings
Hemoglobin should be monitored carefully; targeting levels above 11–12 g/dL is associated with increased risk of cardiovascular events and mortality. The lowest effective dose should be used. Discontinue if pure red cell aplasia is suspected.
How it works
Erythropoietin-beta is a recombinant form of human erythropoietin that stimulates the bone marrow to produce red blood cells by binding to erythropoietin receptors on erythroid progenitor cells, thereby increasing erythropoiesis.
Storage
Store at 2–8°C in a refrigerator. Do not freeze. Protect from light.